INTELLION

Software-as-a-Service (SaaS) services featuring non-downloadable computer software and Platform-as-a-Service (PaaS) non-downloadable computer software services featuring computer software platforms in the nature of non-downloadable computer software, non-downloadable computer applications, and web-based software, all for accessing cloud-based servers and remote client servers for measuring pre and post-surgical cancer, medical, and disease burden scores through bioinformatics and artificial intelligence, analyzing, testing, tracking, and reporting genetic patterns post-pre- and surgery, providing cancer, medical, and disease treatment recommendation, providing high precision personalized cancer, medical, and disease treatment monitoring throughout the patient cancer, medical, and disease encounter, reducing cancer, medical, and disease treatment costs, and accelerated cancer, medical, and disease drug development for use by pharmaceutical companies and laboratories, health systems, oncologists, physicians, cancer clinics, medical professionals, hospitals, and patients

Genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; medical testing and diagnostic services, namely, diagnostic testing, monitoring, tracking, and reporting for detecting minimal residual disease (MRD) by analyzing, testing, tracking, and reporting DNA, genomes, genotype, and genetic mutations using whole genome pattern recognition, low-input liquid blood biopsy, aggregated SNC and CNV signals, and tracking tumor progression as it evolves during the patient treatment and follow up period